Research in Brief [0.03%]
研究简报
Holly Baker
Holly Baker
Vedolizumab for prevention of recurrence of Crohn's disease - Authors' reply [0.03%]
vedolizumab用于预防克罗恩病复发-作者回复
Geert DHaens;REPREVIO investigators
Geert DHaens;REPREVIO investigators
Nassim Hammoudi,Matthieu Allez
Nassim Hammoudi
Andrew Nguyen,Christopher F D Li Wai Suen,Ashish Srinivasan et al.
Andrew Nguyen et al.
Hepatitis B treatment in Africa: learning points from a scale-up programme in Ethiopia [0.03%]
非洲的乙型肝炎治疗:来自埃塞俄比亚的大规模推广方案的经验教训
Hailemichael Desalegn,Lasse Rossvoll,Fufa Hunduma et al.
Hailemichael Desalegn et al.
The Lancet Gastroenterology Hepatology
The Lancet Gastroenterology Hepatology
Breaking the silence: MASLD and the scarcity of data on the Roma population [0.03%]
打破沉默:MASLD和罗姆人口数据的匮乏问题
Paula Iruzubieta,Javier Crespo
Paula Iruzubieta
Pathogens don't respect politicians: US federal disruption poses a new threat to global public health [0.03%]
病原体不尊重政客:美国联邦行动的中断对全球公共卫生构成新的威胁
Su Wang,Mark Harrington,Camilla S Graham et al.
Su Wang et al.
Overcoming the challenges of overtreating and undertreating inflammatory bowel disease [0.03%]
克服炎症性肠病过度治疗和治疗不足的挑战
Maria José Temido,Sailish Honap,Vipul Jairath et al.
Maria José Temido et al.
Several therapeutic advances have been achieved over the past two decades for inflammatory bowel disease (IBD). The expanding therapeutic armamentarium and the increasingly ambitious treatment targets have led to an increased use of advance...
Early antiviral treatment with tenofovir alafenamide to prevent serious clinical adverse events in adults with chronic hepatitis B and moderate or high viraemia (ATTENTION): interim results from a randomised controlled trial [0.03%]
恩曲他滨替诺福韦用于治疗慢性乙肝成人患者的一项随机对照试验(ATTENTION)的中期结果:对于中高病毒载量成人患者,提早用药以预防严重临床不良事件的效果
Young-Suk Lim,Ming-Lung Yu,Jonggi Choi et al.
Young-Suk Lim et al.
Background: Current guidelines for chronic hepatitis B recommend antiviral therapy for individuals with non-cirrhotic chronic hepatitis B only if they have significant liver fibrosis or elevated alanine aminotransferase (...